Latest News for: delcath

Edit

Statement of Changes in Beneficial Ownership (Form 4) (Delcath Systems Inc)

Public Technologies 19 Feb 2026
DELCATH SYSTEMS, INC ... C/O DELCATH SYSTEMS, INC., 566 QUEENSBURY AVENUE 3 ... C/O DELCATH SYSTEMS, INC ... (and subject to the terms and conditions of the Delcath Systems, Inc ... Delcath Systems Inc.
Edit

Ocular melanoma Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Delcath System, ...

GetNews 19 Feb 2026
The Key Ocular melanoma Companies in the market include - Immunocore, Delcath Systems, IDEAYA Biosciences, Aura Biosciences, Linnaeus Therapeutics, Turnstone Biologics, Seagen, IDEAYA, Ascentage Pharma, and others ... Delcath Systems ... Delcath System.
Edit

Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call

Business Wire 12 Feb 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq ... Event Date. Th .
Edit

Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & ...

Business Wire 27 Jan 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... About Delcath Systems, Inc., HEPZATO KIT ...
Edit

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire 22 Jan 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH) (the “Company” or “Delcath”), an ...
Edit

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Delcath Systems Inc)

Public Technologies 21 Jan 2026
21, 2026-- Delcath Systems, Inc ... The RSUs are subject to the employee's continued employment with Delcath on each vesting date ... About Delcath Systems, Inc. Delcath Systems, Inc ... [email protected] ... Delcath Systems, Inc ... Delcath Systems Inc.
Edit

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results (Form 8-K) (Delcath Systems Inc)

Public Technologies 12 Jan 2026
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results. QUEENSBURY, NY - January 9, 2026, Delcath Systems, Inc ... About Delcath Systems, Inc., HEPZATO KIT and CHEMOSAT. Delcath Systems, Inc ... Delcath Systems Inc.
Edit

Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

Business Wire 09 Jan 2026
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH) (“Delcath” or the “Company”), an ...
Edit

Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic ...

Business Wire 31 Dec 2025
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH), (“Delcath” or the “Company”) an ...
Edit

Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic ...

Business Wire 04 Dec 2025
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH), (“Delcath” or the “Company”) an ...
Edit

Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program

Business Wire 21 Nov 2025
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH), (“Delcath”) an interventional ...
Edit

Material Event (Form 8-K) (Delcath Systems Inc)

Public Technologies 20 Nov 2025
On November 19, 2025, the board of directors of Delcath Systems, Inc., a Delaware corporation (the ... Delcath Systems Inc.
Edit

Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases ...

Business Wire 18 Nov 2025
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc ... DCTH), (“Delcath” or the “Company”) an ...
  • 1

Article Search

tools
×
×
×
×